Matthew Ferguson - Jul 31, 2024 Form 4 Insider Report for ELUTIA INC. (ELUT)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Jeffrey Hamet, Attorney-in-Fact for Matthew Ferguson
Stock symbol
ELUT
Transactions as of
Jul 31, 2024
Transactions value $
$150,002
Form type
4
Date filed
7/31/2024, 05:00 PM
Previous filing
Jun 12, 2024
Next filing
Aug 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELUT Class A Common Stock Options Exercise $150K +105K +68.8% $1.43 258K Jul 31, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELUT Warrants (rights to buy) Options Exercise $0 -105K -100% $0.00* 0 Jul 31, 2024 Class A Common Stock 105K $1.43 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction represents shares of the Issuer's Class A Common Stock received from the exercise of the warrant dated September 21, 2023.
F2 The warrant expires upon the earlier of (a) 30 trading days after the clearance by the U.S. Food & Drug Administration of the issuer's CanGarooRM antibiotic-eluting biologic envelope or (b) September 21, 2028.